請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27825
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 江炯聰 | |
dc.contributor.author | Chun-Ming Huang | en |
dc.contributor.author | 黃俊銘 | zh_TW |
dc.date.accessioned | 2021-06-12T18:22:38Z | - |
dc.date.available | 2007-08-28 | |
dc.date.copyright | 2007-08-28 | |
dc.date.issued | 2007 | |
dc.date.submitted | 2007-08-20 | |
dc.identifier.citation | Yearbook of Biotechnology Industry 2006/ Development Center for Biotechnology
GPN: 1009500959 ISBN: 957-8514-69-7 A Survey of the Use of Biotechnology in U.S. Industry Technology Administration, U.S. Department of Commerce, October 2003. http://www.technology.gov/reports/Biotechnology/CD120a_0310.pdf Frequently Asked Questions about Biotechnology U.S. Department of State Fact Sheet, March 21, 2000. http://usinfo.state.gov/ei/economic_issues/biotechnology/biotech_faq.html Beyond Therapy: Biotechnology and the Pursuit of Happiness The President's Council on Bioethics, Washington, D.C., October 2003. An inquiry into the potential implications of using biotechnology beyond therapy,?in order to try to satisfy deep and familiar human desires: for better children, superior performance, ageless bodies, and happy souls. http://www.bioethics.gov/reports/beyondtherapy/index.html United States Regulatory Oversight in Biotechnology Responsible Agencies - Overview U.S. Department of Agriculture. The Agencies primarily responsible for regulating biotechnology in the United States are the US Department of Agriculture (USDA), Environmental Protection Agency (EPA), and the Food and Drug Administration (FDA). Products are regulated according to their intended use, with some products being regulated under more than one agency. http://www.aphis.usda.gov/brs/usregs.html USDA Announces First Steps To Update Biotechnology Regulations U.S. Department of Agriculture Press Release Jan 22, 2004. Agriculture Secretary Ann M. Veneman announces USDA intention to update and strengthen its biotechnology regulations for the importation, interstate movement and environmental release of certain genetically engineered (GE) organisms. http://www.usda.gov/Newsroom/0033.04.htm About The Human Genome Project National Human Genome Research Institute, updated February 2004. http://www.genome.gov/10001772 A Vision for the Future of Genomics Research National Human Genome Research Institute, reprinted from 'Nature', April 14, 2003. http://www.genome.gov/Pages/About/vision.pdf National Center for Biotechnology Information www.ncbi.nlm.nih.gov/ The Promise of Biotechnology, eJournal USA: Economic Perspectives ... www.usinfo.state.gov/journals/ites/1005/ijee/ijee1005.htm OECD biotechnology newsletter updates www.oecd.org/document/52/0,3343,en_2649_37437_2078004_1_1_1_37437,00.html BioTrack Product Database - Home page www.2.oecd.org/biotech/ Biotechnology: USA (Atlanta) By 2001, the United States Patent and Trademark Office (USPTO) received 34527 biotechnology patent applications. A new report indicates patents on genes and proteins--representing potential drug targets--are quickly becoming the ... www.giichinese.com.tw/chinese/dm33791-postgenomic.html Pharmaceutical market World pharmaceutical market. Year 1996,1997,1998, 1999, 2000, 2001, 2002 2003, 2004 ... USA: US$ 417m Japan: US$ 445m. 1998 2004. Frost & Sullivan. WM cell therapies and tissue repair. cell therapies: US$ 14.572bn ... www.i-s-b.org/business/pharma.htm Taiwan Yearbook 2004 Government biotechnology R&D expenditures in 2003 was about US$485 million. Taiwan and its people have various ... The government has constructed a blueprint for the special biotech and medical area in the Hsinchu Science Park. ... www.ecommerce.taipeitimes.com/yearbook2004/P177.htm BioEconomy These are not targets to be left on the shelf: the USA has a clear commitment to their achievement. .... An action plan covering biotechnology strategy guidelines was published by the government-sponsored Biotechnology Strategy Council ... www.bio-economy.net/centre3.html | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/27825 | - |
dc.description.abstract | 生技產業是許多國家想要發展的領域。然而,什麼是生技產業,可能有不同的看法與定義。本文首先給生技定義並舉出在產業上的應用及其在財政與經濟上的衝擊。
從生技產業萌芽開始,美國就領導世界的生技產業。本文第二部分,從世界產業競爭的角度,探討美國生技產業的地位。並分析美國生技產業的成功因素,並找出四個成功因素。第一個因素是從聯邦政府與產業界來的巨大研發投資。第二是政府在策略,法規,與立法方面的鼓勵措施。第三是從市場面分析,而美國是世界最大的藥品市場,有50%的市占率。最後一個因素是健全的資本市場,包括股市與創投。 最後,則以美國的成功因素來分析台灣生技產業的發展,並嘗試指出其產業發展的策略意涵。 | zh_TW |
dc.description.abstract | Biotechnology is one of the scientific fields that many countries would like to encourage and develop. However, what is the scope of biotechnology industry? There might have different views and definition. In this article, it first gives the definition of biotechnology and its industrial applications and its impacts financial and economic fields.
From the blooming of biotechnology industries, USA has been the leading country in the world. In the second paragraph, the article discusses development of biotechnology in USA from the global point of views, and positions the US biotech industry among the international competition, to evaluate the successful factors of US biotech industry. There are four aspects being analyzed and identified. The first is the huge investment in research and development from the Federal government and from the industry. The second is the governmental strategies, regulations, and laws to encourage the industry. The third is the market capacity, since the US is occupying 50% of the total pharmaceutical market in the world. The last one is the capital market is very friendly to the biotech industry, with very mature stock markets and venture capitals. The last paragraph analyzes the gaps of Taiwan in the development of biotech industry based on the successful factors found in the US counterpart, and tries to make the recommendations and conclusions in terms of strategic implications. | en |
dc.description.provenance | Made available in DSpace on 2021-06-12T18:22:38Z (GMT). No. of bitstreams: 1 ntu-96-R90741019-1.pdf: 862592 bytes, checksum: 48d087c8b3eec949001038e74f57ce25 (MD5) Previous issue date: 2007 | en |
dc.description.tableofcontents | Table of Contents
口試委員審定書 誌謝……………………………………………………………….. 2 中文摘要 ………………………………………………………………… 3 英文摘要 ………………………………………………………………… 4 I: What is Biotechnology: The Definition and Background Information of Biotechnology ……………………………………………………………...8 I.1 The Definition of Biotechnology ……………………………………….8 I.2 The Impact and Challenges of Biotechnology ………………………...16 II The Development of Biotechnology Industry in USA: From the Global Point of Views …………………………………………………………….22 II.1 The Position and Development of Biotechnology Industry in USA among the International Competition ……………………………………..22 II.1 a : The Global Aspects ……………………………………………….22 II.2 The Biotechnology Industry in USA …………………………………31 II.2.a The Strategic and Economic Aspects of Biotechnology in USA ..…31 II.2.b The Current Development of Biotechnology Industry in USA ……35 II.2.c The Successful Factors of Biotechnology Industry in USA…………38 II.3: The Successful Factors from the Analysis……………………………39 II.3.1: The R&D Basis: the federal government and industry……………...39 II.3.2: The Governmental Strategies……………………………………....51 II.3.3: The Market for Pharmaceutical and Biotechnological Products…...54 II.3.4: The Capital Market: Venture capital and financial markets………...61 III: TAIWAN: Could we Succeed? And How? ……………………………65 III.I: Background Information……………………………………………...65 III.2: The Checking Criteria for the Successful Factors……………………67 III.2.1: The Checking Criteria: the R&D Capacity of Biotechnology in Taiwan……………………………………………………………………...67 III.2.2: The Checking Criteria: the Governmental Strategies……………...73 III.2.3: The Checking Criteria: the Market for Pharmaceutical and Biopharmaceutical Products……………………………………………….74 III.2.4: The Checking Criteria: The Capital Market—the Venture Capitals and Financial Markets …………………………………………………….77 IV: The Conclusion ……………………………………………………….82 Reference…………………………………………………………………..84 | |
dc.language.iso | zh-TW | |
dc.title | 美國生技產業分析及其對台灣的策略意涵 | zh_TW |
dc.title | An Analysis of US Biotechnology Industry and its Strategic Implications for Taiwan | en |
dc.type | Thesis | |
dc.date.schoolyear | 95-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 張睿詒,承立平 | |
dc.subject.keyword | 生物技術,專利,製藥, | zh_TW |
dc.subject.keyword | biotechnology,patent,pharmaceutical, | en |
dc.relation.page | 86 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2007-08-20 | |
dc.contributor.author-college | 管理學院 | zh_TW |
dc.contributor.author-dept | 商學組 | zh_TW |
顯示於系所單位: | 商學組 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-96-1.pdf 目前未授權公開取用 | 842.38 kB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。